The effect of vitamin D status on ovarian reserve markers in infertile women: A prospective cross-sectional study


Background: Vitamin D deficiency and infertility are two important health problems in Iran. Some studies suggest that vitamin D may influence Anti-Müllerian hormone (AMH) and antral follicle count (AFC) as an ovarian reserve.

Objective: The present study aimed to investigate the impact of vitamin D on AMH serum concentrations/AFC.

Materials and Methods: three hundred and five infertile women referred to the IVF Unit of Yas hospital, between July and December 2017, were enrolled in this cross-sectional study. The demographic characteristics of the participants, as well as the serum levels of vitamin D, AMH, and ultrasonic examination of AFC were recorded.

Results: Finally, 287 infertile women were included in the analysis with a mean age of 29.95 ± 4.73 yr (18-45 yr) and a mean Body mass indexof 25.11 ± 4.41 kg/m2. The median AMH and vitamin D levels were 3.20 and 22.82 ng/ml, respectively. Considering the cut-off level of 20 ng/ml, 58.7% were vitamin D deficient. Regression analysis showed no association between AMH and vitamin D levels (p = 0.161), even after adjusting for baseline variables (p = 0.182). A total of 120 patients had an AFC < 6 and 164 ≥ 6, which was not statistically different between the groups with normal level or deficient vitamin D (p = 0.133).

Conclusion: The present cross-sectional study showed no significant association between serum levels of vitamin D and AMH or AFC in infertile women, even after adjusting for baseline variables.

Key words: Anti-Müllerian hormone, Infertility, Vitamin D deficiency, Ovarian follicle.

[1] Fondjo LA, Owiredu WKBA, Sakyi SA, Laing EF, Adotey- Kwofie MA, Antoh EO, et al. Vitamin D status and its association with insulin resistance among type 2 diabetics: A case-control study in Ghana. PloS One 2017; 12: e0175388.

[2] Wang H, Chen W, Li D, Yin X, Zhang X, Olsen N, et al. Vitamin D and chronic diseases. Aging Dis 2017; 8: 346–353.

[3] Pludowski P, Holick MF, Pilz S, Wagner CL, Hollis BW, Grant WB, et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmu Rev 2013; 12: 976–989.

[4] Hovsepian S, Amini M, Aminorroaya A, Amini P, Iraj B. Prevalence of vitamin D deficiency among adult population of Isfahan City, Iran. J Health Popul Nutr 2011; 29: 149–155.

[5] Ranjana H. Role of vitamin D in infertility. J Public Health Policy Plann 2017; 1: 8–10.

[6] Akhondi MM, Kamali K, Ranjbar F, Shirzad M, Shafeghati S, Behjati Ardakani Z, et al. Prevalence of primary infertility in Iran in 2010. Iran J Public Health 2013; 42: 1398–1404.

[7] Pacis MM, Fortin CN, Zarek SM, Mumford SL, Segars JH. Vitamin D and assisted reproduction: should vitamin D be routinely screened and repleted prior to ART? A systematic review. J Assist Reprod Genet 2015; 32: 323–335.

[8] Aleyasin A, Hosseini MA, Mahdavi A, Safdarian L, Fallahi P, Mohajeri MR, et al. Predictive value of the level of vitamin D in follicular fluid on the outcome of assisted reproductive technology. Eur J Obstet Gynecol Reprod Biol 2011; 159: 132–137.

[9] Lima ML, Martins WP, Coelho Neto MA, Nastri CO, Ferriani RA, Navarro PA. Assessment of ovarian reserve by antral follicle count in ovaries with endometrioma. Ultrasound Obstet Gynecol 2015; 46: 239–242.

[10] Zec I, Tislaric-Medenjak D, Megla ZB, Kucak I. Anti- Mullerian hormone: a unique biochemical marker of gonadal development and fertility in humans. Biochem Med 2011; 21: 219–230.

[11] Fleming R, Seifer DB, Frattarelli JL, Ruman J. Assessing ovarian response: antral follicle count versus anti-Müllerian hormone. Reprod Biomed Online 2015; 31: 486–496.

[12] Merhi Z, Doswell A, Krebs K, Cipolla M. Vitamin D alters genes involved in follicular development and steroidogenesis in human cumulus granulosa cells. J Clin Endocrinol Metab 2014; 99: E1137–E1145.

[13] Irani M, Merhi Z. Role of vitamin D in ovarian physiology and its implication in reproduction: a systematic review. Fertil Steril 2014; 102: 460–468. e3.

[14] Dicken CL, Israel DD, Davis JB, Sun Y, Shu J, Hardin J, et al. Peripubertal vitamin D3 deficiency delays puberty and disrupts the estrous cycle in adult female mice. Biol Reprod 2012; 87: 51–62.

[15] Wojtusik J, Johnson PA. Vitamin D regulates anti-Mullerian hormone expression in granulosa cells of the hen. Biol Reprod 2012; 86: 91–97.

[16] Drakopoulos P, van de Vijver A, Schutyser V, Milatovic S, Anckaert E, Schiettecatte J, et al. The effect of serum vitamin D levels on ovarian reserve markers: a prospective cross-sectional study. Hum Reprod 2016; 32: 208–214.

[17] Pearce K, Gleeson K, Tremellen K. Serum anti-Mullerian hormone production is not correlated with seasonal fluctuations of vitamin D status in ovulatory or PCOS women. Hum Reprod 2015; 30: 2171–2177.

[18] Dennis NA, Houghton LA, Jones GT, van Rij AM, Morgan K, McLennan IS. The level of serum anti-Müllerian hormone correlates with vitamin D status in men and women but not in boys. J Clin Endocrinol Metab 2012; 97: 2450–2455.

[19] Garg D, Tal R. The role of AMH in the pathophysiology of polycystic ovarian syndrome. Reprod Biomed Online 2016; 33: 15–28.

[20] Vilarino FL, Bianco B, Lerner TG, Teles JS, Mafra FA, Christofolini DM, et al. Analysis of vitamin D receptor gene polymorphisms in women with and without endometriosis. Hum Immunol 2011; 72: 359–363.

[21] Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911–1930.

[22] Tabrizi R, Moosazadeh M, Akbari M, Dabbaghmanesh MH, Mohamadkhani M, Asemi Z, et al. High prevalence of vitamin D deficiency among Iranian population: a systematic review and meta-analysis. Iran J Med Sci 2018; 43: 125–139.

[23] Hassannia T, GhaznaviRad E, Vakili R, Taheri S, Rezaee SA. High prevalence of vitamin d deficiency and associated risk factors among employed women in a sunny Industrial City. Int J Vitam Nutr Res 2015; 85: 119–128.

[24] Naseh A, Ashrafzadeh S, Rassi S. Prevalence of vitamin D deficiency in pregnant mothers in Tehran and investigating its association with serum glucose and insulin. J Maternal- Fetal Neonat Med 2017; 31: 2312–2318.

[25] Emdadi R, Chaichian S, Mahboubi M, Moradi Y, Akhlaghdoust M, Basharkhah A. Prevalence of vitamin D deficiency among women of reproductive age: a multi centric study in Tehran. Shiraz E-Med J 2016; 17: e40745.

[26] Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF, et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 2010; 106: 963–968.

[27] Lerchbaum E, Rabe T. Vitamin D and female fertility. Curr Opin Obstet Gynecol 2014; 26: 145–150.

[28] Pagliardini L, Vigano P, Molgora M, Persico P, Salonia A, Vailati SH, et al. High prevalence of vitamin D deficiency in infertile women referring for assisted reproduction. Nutrients 2015; 7: 9972–9984.

[29] Lee Y, Kim TH, Park JK, Eum JH, Lee HJ, Kim J, et al. Predictive value of antral follicle count and serum antiMullerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment? Eur J Obstet Gynecol Reprod Biol 2018; 221: 151–155.

[30] Bas-Lando M, Rabinowitz R, Farkash R, Algur N, Rubinstein E, Schonberger O, et al. Prediction value of anti-Mullerian hormone (AMH) serum levels and antral follicle count (AFC) in hormonal contraceptive (HC) users and non-HC users undergoing IVF-PGD treatment. Gynecol Endocrinol 2017; 33: 797–800.

[31] Hoorsan H, Mirmiran P, Chaichian Sh, Moradi Y, Akhlaghdoust M, Hoorsan R, et al. Diet and risk of endometriosis: a systematic review and meta-analysis study. Iran Red Crescent Med J 2017; 19: e41248.

[32] Naderi Z, Kashanian M, Chenari L, Sheikhansari N. Evaluating the effects of administration of 25- hydroxyvitamin D supplement on serum anti-mullerian hormone (AMH) levels in infertile women. Gynecol Endocrinol 2017; 34: 409–412.